302 related articles for article (PubMed ID: 24282346)
1. Has the risk of colorectal cancer in inflammatory bowel disease decreased?
Andersen NN; Jess T
World J Gastroenterol; 2013 Nov; 19(43):7561-8. PubMed ID: 24282346
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
Dyson JK; Rutter MD
World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
[TBL] [Abstract][Full Text] [Related]
3. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
4. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies.
Lutgens MW; van Oijen MG; van der Heijden GJ; Vleggaar FP; Siersema PD; Oldenburg B
Inflamm Bowel Dis; 2013; 19(4):789-99. PubMed ID: 23448792
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer in inflammatory bowel disease: review of the evidence.
Keller DS; Windsor A; Cohen R; Chand M
Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
[TBL] [Abstract][Full Text] [Related]
6. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
[TBL] [Abstract][Full Text] [Related]
7. Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah.
Jewel Samadder N; Valentine JF; Guthery S; Singh H; Bernstein CN; Wan Y; Wong J; Boucher K; Pappas L; Rowe K; Bronner M; Ulrich CM; Burt RW; Curtin K; Smith KR
Dig Dis Sci; 2017 Aug; 62(8):2126-2132. PubMed ID: 28050782
[TBL] [Abstract][Full Text] [Related]
8. Carcinogenesis in inflammatory bowel disease.
Herszenyi L; Miheller P; Tulassay Z
Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
[TBL] [Abstract][Full Text] [Related]
9. Who and how to screen for cancer in at-risk inflammatory bowel disease patients.
Parian A; Lazarev M
Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):731-46. PubMed ID: 25592672
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.
Zheng HH; Jiang XL
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):383-90. PubMed ID: 26938805
[TBL] [Abstract][Full Text] [Related]
11. Primary sclerosing cholangitis associated with inflammatory bowel disease: an update.
Rossi RE; Conte D; Massironi S
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):123-31. PubMed ID: 26636407
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer in elderly-onset inflammatory bowel disease: a 1969-2017 Scandinavian register-based cohort study.
Everhov ÅH; Erichsen R; Järås J; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sørensen HT; Olén O
Aliment Pharmacol Ther; 2022 Oct; 56(7):1168-1182. PubMed ID: 35916190
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis.
Wijnands AM; de Jong ME; Lutgens MWMD; Hoentjen F; Elias SG; Oldenburg B;
Gastroenterology; 2021 Apr; 160(5):1584-1598. PubMed ID: 33385426
[TBL] [Abstract][Full Text] [Related]
14. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
[TBL] [Abstract][Full Text] [Related]
15. Interval Colorectal Cancer in Inflammatory Bowel Disease: A Review.
Da Cunha T; Vaziri H
J Clin Gastroenterol; 2024 Jan; 58(1):1-11. PubMed ID: 37548445
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer surveillance in inflammatory bowel disease: the search continues.
Ahmadi A; Polyak S; Draganov PV
World J Gastroenterol; 2009 Jan; 15(1):61-6. PubMed ID: 19115469
[TBL] [Abstract][Full Text] [Related]
17. Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series.
Barberio B; Savarino E; Verstockt B; Fumery M; Pugliese D; Bertani L; Buda A; Dragoni G; Goren I; Laish I; Spinelli A; Teich N; Truyens M; Ellul P
J Crohns Colitis; 2022 Dec; 16(12):1845-1852. PubMed ID: 35771951
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer prognosis among patients with inflammatory bowel disease.
Delaunoit T; Limburg PJ; Goldberg RM; Lymp JF; Loftus EV
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697
[TBL] [Abstract][Full Text] [Related]
19. Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies.
Lakatos PL; Lakatos L
World J Gastroenterol; 2008 Jul; 14(25):3937-47. PubMed ID: 18609676
[TBL] [Abstract][Full Text] [Related]
20. Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease.
Aalykke C; Jensen MD; Fallingborg J; Jess T; Langholz E; Meisner S; Andersen NN; Riis LB; Thomsen OØ; Tøttrup A
Dan Med J; 2015 Jan; 62(1):B4995. PubMed ID: 25557336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
